Abstract
Intelligent Prescription Systems (IPS) represent a promising frontier in healthcare, offering the potential
to optimize medication selection, dosing, and monitoring tailored to individual patient needs. This comprehensive
review explores the current landscape of IPS, encompassing various technological approaches, applications,
benefits, and challenges. IPS leverages advanced computational algorithms, machine learning techniques,
and big data analytics to analyze patient-specific factors, such as medical history, genetic makeup, biomarkers,
and lifestyle variables. By integrating this information with evidence-based guidelines, clinical decision
support systems, and real-time patient data, IPS generates personalized treatment recommendations that
enhance therapeutic outcomes while minimizing adverse effects and drug interactions. Key components of IPS
include predictive modeling, drug-drug interaction detection, adverse event prediction, dose optimization, and
medication adherence monitoring. These systems offer clinicians invaluable decision-support tools to navigate
the complexities of medication management, particularly in the context of polypharmacy and chronic disease
management. While IPS holds immense promise for improving patient care and reducing healthcare costs, several
challenges must be addressed. These include data privacy and security concerns, interoperability issues, integration
with existing electronic health record systems, and clinician adoption barriers. Additionally, the regulatory
landscape surrounding IPS requires clarification to ensure compliance with evolving healthcare regulations.
Despite these challenges, the rapid advancements in artificial intelligence, data analytics, and digital
health technologies are driving the continued evolution and adoption of IPS. As precision medicine gains momentum,
IPS is poised to play a central role in revolutionizing medication management, ultimately leading to
more effective, personalized, and patient-centric healthcare delivery.
Keywords:
Intelligent prescription systems, precision medicine, artificial intelligence, electronic health records, personalized medicine, biomarkers.
[3]
Suryadevara CK. Towards personalized healthcare-an intelligent medication recommendation system. IEJRD-Int Multidiscipl J 2020; 5(9): 16.
[6]
Gimenes FR, Miasso AI, de Lyra DP Junior, Grou CR. Electronic prescription as contributing factor for hospitalized patients’ safety. Pharm Pract 2006; 4(1): 13-7.
[17]
Sigerist HE. A history of medicine. Oxford University Press 1987; 2: pp. 1-20.
[19]
Jackson M, Ed. A global history of medicine. Oxford University Press 2018.
[23]
Tariq MU. Revolutionizing health data management with blockchain technology: Enhancing security and efficiency in a digital era. Emerging Technologies for Health Literacy and Medical Practice. IGI Global 2024; pp. 153-75.
[31]
Preuss C V, Kalava A, King K C. Prescription of controlled substances: benefits and risks. Treasure Island (FL): StatPearls Publishing 2019.
[32]
Omboni S, Padwal R S, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: Current evidence and recommendations for the future. Connect Health 2022; 1: 7-35.
[34]
Sinthiya S, Udayadhara A, Gomathy B. Effects of electronic prescription on the clinical practice. Automation and Autonomous
Systems. Ischolar 2016; 8(2): 34-6.
[39]
Ognibene PJ. Smart Pharmacy Cards to automate patient records for patient-reported outcomes (PROs) pective drug utilization review. Proceedings of the Annual Symposium on Computer Application in Medical Care. American Medical Informatics Association 1991; p. 906.
[48]
Sigerist HE. A history of medicine. Oxford University Press 1987; 2: pp. 1-20.
[50]
Jackson M, Ed. A global history of medicine. Oxford University Press 2018.
[51]
Shahid AH, Khattak WA. Improving patient care with machine learning: A game-changer for healthcare. Appl Res Artif Intell Cloud Comp 2022; 5(1): 150-63.
[53]
Gaikwad RK. Comprehensive Evaluation of Two Electronic Medical Record (EMR) Systems in Primary Health Care for Accuracy of Drug Interaction Alerts. Doctoral dissertation, Dalhousie University 2005.
[54]
Tantray J, Zaid M, Kosey S, et al. Pharmacovigilance: A meta-analysis on ADRS of past and recent tragedy occurred in Gambia. J Pharmacovigil 2023; 11(1): 409.
[59]
Preuss C V, Kalava A, King K C. Prescription of controlled substances: benefits and risks. Treasure Island (FL): StatPearls Publishing 2019.
[80]
Houghton J. Information technology and the revolution in healthcare. Digital Medicine Health Informatics. Cham: Springer 2002; pp. 1-7.
[81]
Emuoyibofarhe OJ, Omotosho A. Development of a secure intelligent e-prescription system. Proceedings of The International eHealth, Telemedicine and Health ICT Forum for Education, Networking and Business (Med Tel 2012) Conference. 261-72.
[84]
Lt K. To err is human: building a safer health system. Washington (DC): National Academies Press (US) 2000.
[92]
McKibbon KA, Lokker C, Handler SM, et al. Enabling medication management through health information technology. Evid Rep Technol Assess 2011; 201: 1-951.
[105]
Ghazal L, Saleem Z, Amlani G. A medical error: To disclose or not to disclose. J Clin Res Bioeth 2014; 5: 1.
[112]
Department of Health. An Organisation with a Memory: Report of an Expert Group on Learning from Adverse Events in the NHS Chaired by the Chief Medical Officer. London, UK: HM Stationery Office 2000.